We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Bile Acid Tethered Docetaxel‐Based Nanomicelles Mitigate Tumor Progression through Epigenetic Changes.
- Authors
Sreekanth, Vedagopuram; Kar, Animesh; Kumar, Sandeep; Pal, Sanjay; Yadav, Poonam; Sharma, Yamini; Komalla, Varsha; Sharma, Harsh; Shyam, Radhey; Sharma, Ravi Datta; Mukhopadhyay, Arnab; Sengupta, Sagar; Dasgupta, Ujjaini; Bajaj, Avinash
- Abstract
In this study, we describe the engineering of sub‐100 nm nanomicelles (DTX‐PC NMs) derived from phosphocholine derivative of docetaxel (DTX)‐conjugated lithocholic acid (DTX‐PC) and poly(ethylene glycol)‐tethered lithocholic acid. Administration of DTX‐PC NMs decelerate tumor progression and increase the mice survivability compared to Taxotere (DTX‐TS), the FDA‐approved formulation of DTX. Unlike DTX‐TS, DTX‐PC NMs do not cause any systemic toxicity and slow the decay rate of plasma DTX concentration in rodents and non‐rodent species including non‐human primates. We further demonstrate that DTX‐PC NMs target demethylation of CpG islands of Sparcl1 (a tumor suppressor gene) by suppressing DNA methyltransferase activity and increase the expression of Sparcl1 that leads to tumor regression. Therefore, this unique system has the potential to improve the quality of life in cancer patients and can be translated as a next‐generation chemotherapeutic.
- Subjects
CANCER invasiveness; BILE acids; PHOSPHOCHOLINE; TUMOR suppressor genes; DNA methyltransferases; EPIGENETICS; POLYCARBONATES; ALKALOIDS
- Publication
Angewandte Chemie, 2021, Vol 133, Issue 10, p5454
- ISSN
0044-8249
- Publication type
Article
- DOI
10.1002/ange.202015173